403 related articles for article (PubMed ID: 24205729)
1. [Treatment of hypertriglyceridemia with omega-3 fatty acids].
Miyoshi T; Ito H
Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids for cardioprotection.
Lee JH; O'Keefe JH; Lavie CJ; Marchioli R; Harris WS
Mayo Clin Proc; 2008 Mar; 83(3):324-32. PubMed ID: 18316000
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and cardiovascular disease: new developments and applications.
Harris WS; Dayspring TD; Moran TJ
Postgrad Med; 2013 Nov; 125(6):100-13. PubMed ID: 24200766
[TBL] [Abstract][Full Text] [Related]
4. Update on marine omega-3 fatty acids: management of dyslipidemia and current omega-3 treatment options.
Weintraub H
Atherosclerosis; 2013 Oct; 230(2):381-9. PubMed ID: 24075771
[TBL] [Abstract][Full Text] [Related]
5. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.
Harris WS; Miller M; Tighe AP; Davidson MH; Schaefer EJ
Atherosclerosis; 2008 Mar; 197(1):12-24. PubMed ID: 18160071
[TBL] [Abstract][Full Text] [Related]
7. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.
Pirillo A; Catapano AL
Drug Des Devel Ther; 2015; 9():2129-37. PubMed ID: 25914523
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
[TBL] [Abstract][Full Text] [Related]
9. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia.
Pirillo A; Catapano AL
Int J Cardiol; 2013 Dec; 170(2 Suppl 1):S16-20. PubMed ID: 23856442
[TBL] [Abstract][Full Text] [Related]
11. Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors.
Ryan AS; Keske MA; Hoffman JP; Nelson EB
Am J Ther; 2009; 16(2):183-92. PubMed ID: 19145206
[TBL] [Abstract][Full Text] [Related]
12. Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids.
Kris-Etherton PM; Richter CK; Bowen KJ; Skulas-Ray AC; Jackson KH; Petersen KS; Harris WS
Methodist Debakey Cardiovasc J; 2019; 15(3):171-178. PubMed ID: 31687095
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids from fish oils and cardiovascular disease.
Holub DJ; Holub BJ
Mol Cell Biochem; 2004 Aug; 263(1-2):217-25. PubMed ID: 15524182
[TBL] [Abstract][Full Text] [Related]
14. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid (DHA) and cardiovascular disease risk factors.
Holub BJ
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):199-204. PubMed ID: 19545988
[TBL] [Abstract][Full Text] [Related]
16. History and future of omega-3 fatty acids in cardiovascular disease.
Sperling LS; Nelson JR
Curr Med Res Opin; 2016; 32(2):301-11. PubMed ID: 26566071
[TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.
Tatsuno I
Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1261-8. PubMed ID: 25319059
[TBL] [Abstract][Full Text] [Related]
19. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
Rupp H
Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
[TBL] [Abstract][Full Text] [Related]
20. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study.
De Luis DA; Conde R; Aller R; Izaola O; González Sagrado M; Perez Castrillón JL; Dueñas A; Romero E
Eur Rev Med Pharmacol Sci; 2009; 13(1):51-5. PubMed ID: 19364085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
